Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $65.60.

A number of analysts have recently issued reports on ASTH shares. Macquarie upgraded Astrana Health to a “hold” rating in a research report on Monday, December 16th. Stifel Nicolaus reduced their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Robert W. Baird boosted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, Truist Financial cut their price objective on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th.

Hedge Funds Weigh In On Astrana Health

A number of institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC purchased a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $35,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Astrana Health in the fourth quarter valued at approximately $40,000. Quarry LP grew its position in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after acquiring an additional 471 shares during the period. KBC Group NV acquired a new stake in Astrana Health during the third quarter worth $70,000. Finally, Quest Partners LLC purchased a new stake in Astrana Health in the third quarter valued at $133,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

ASTH opened at $25.38 on Friday. The firm’s fifty day simple moving average is $34.84 and its two-hundred day simple moving average is $44.50. Astrana Health has a 52-week low of $23.12 and a 52-week high of $63.20. The company has a market cap of $1.43 billion, a price-to-earnings ratio of 19.52, a PEG ratio of 1.37 and a beta of 1.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Equities analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.